Keywords
Expanded Neonatal Screening
Pediatricians
Survey
Colombia
How to Cite
Abstract
Introduction: Neonatal screening is a public health tool for early detection of diseases in asymptomatic periods, with intervention options. This aims to impact morbidity and mortality in pediatric age. Objetive: To assess the perception of Colombian pediatricians regarding the expansion of neonatal screening and its practices beyond those currently known. Methods: A cross-sectional analytical study was conducted through an online survey involving 748 participants. Initially, a univariate analysis was performed on usual practices and the perception of expansion. Subsequently, a bivariate analysis was conducted on individual perception by diseases for screening, known screening practices, and familiarity with suggested screening pathologies. Results: Of all the surveyed physicians, 96.3% agreed on implementing neonatal screening. Hypothyroidism was the pathology with the highest physician contact, and hip screening was the most commonly performed test. Concerning the cost-effectiveness of these tests, less than 70% considered them cost-effective, and there was variability in the importance of screening concerning individual pathologies. Cardiac pathologies, jaundice screening, and red reflex assessment appeared to have greater importance in relation to knowledge or contact with these diseases. Conclusions: The vast majority of physicians support expanding neonatal screening, believing it could enhance pediatric health outcomes. However, uncertainty exists regarding the healthcare system’s support to complement the norm.
References
Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJC, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015; 39(3): 171–187. https://doi.org/10.1053/j.semperi.2015.03.002
El-Hattab AW, Almannai M, Scaglia F. Newborn screening: History, current status, and future directions. Pediatr Clin North Am. 2018; 65(2): 389–405. doi: https://doi.org/10.1016/j.pcl.2017.11.014
Almannai M, Marom R, Sutton VR. Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr Opin Pediatr. 2016; 28(6): 694–699. doi: https://doi.org/10.1097/MOP.0000000000000416
Bermúdez AJ, Valera D de los Á, Robayo DB, Ascencio A, Ching RB. Desarrollo de la tamización neonatal en Colombia: espectrometría de masas en tándem. Pediatria (Santiago). 2015; 48(2): 47–54.
Valera Antequera D, Montealegre Páez AL, Bermúdez A, García Robles R. Importancia de una propuesta para la implementación de un programa de tamizaje neonatal expandido en Colombia. Rev Med. 2020; 27(2): 21–33. https://doi.org/10.18359/rmed.4416
Congreso de la República de Colombia. Ley 1980 de 2019: Por medio de la cual se crea el Programa de Tamizaje Neonatal en Colombia. Bogotá: Congreso de la República; 2019.
Castilla-Rodríguez I, Vallejo-Torres L, Couce ML, Valcárcel-Nazco C, Mar J, Serrano-Aguilar P. Cost-effectiveness methods and newborn screening assessment. Adv Exp Med Biol. 2017; 1031: 267–281. doi: https://doi.org/10.1007/978-3-319-69535-4_14
Autti-Rämö I, Mäkelä M, Sintonen H, Koskinen H, Lanning P, Lindholm P. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland. Acta Paediatr. 2005; 94(8): 1126–1136. doi: https://doi.org/10.1111/j.1651-2227.2005.tb02053.x
Cifuentes RA. Consideraciones bioéticas del tamizaje neonatal: pautas para su regulación integral. Rev Latinoam Bioética. 2016; 16(1): 154–173. doi: https://doi.org/10.18359/rlbi.1802
Johnson KA, Catanzarite V. The term newborn: Postnatal screening and testing. Clin Perinatol. 2021; 48(3): 555–572. doi: https://doi.org/10.1016/j.clp.2021.06.002
Acharya K, Ackerman PD, Ross LF. Pediatricians’ attitudes toward expanding newborn screening. Pediatrics. 2005; 116(4): e474–484. doi: https://doi.org/10.1542/peds.2004-2415
Franková V, Dohnalová A, Pešková K, Hermánková R, O’Driscoll R, Ješina P, et al. Factors influencing parental awareness about newborn screening. Int J Neonatal Screen. 2019; 5(3): 35. doi: https://doi.org/10.3390/ijns5030035
Amalakanti S, Raman Arepalli KV, Suvvari TK, Jillella JP. Perception towards newborn screening. J Med Evid. 2023; 4(1): 34–36. doi: https://doi.org/10.4103/JME.JME_21_23
Jones E, Taylor B, MacArthur C, Bradshaw S, Hope L, Cummins C. Early postnatal discharge for infants: A meta-analysis. Pediatrics. 2020; 146(3). doi: https://doi.org/10.1542/peds.2020-0316
Bernal JE, Tamayo ML, Briceño I, Benavides E. Newborn screening in Colombia: The experience of a private program in Bogotá. Biomedica. 2024; 44(1): 102–107. doi: https://doi.org/10.7705/biomedica.6520
Rosselli D, Rueda JD, Ruiz-Patiño A. Análisis de costos de la tamización neonatal universal mediante espectrometría de masas en tándem para errores innatos del metabolismo en Colombia. Pediatria (Santiago). 2014; 47(3): 68–73.
Toli A, Perente A, Labiris G. Evaluation of the red reflex: An overview for the pediatrician. World J Methodol. 2021; 11(5): 263–277. doi: https://doi.org/10.5662/wjm.v11.i5.263
Abouk R, Grosse SD, Ailes EC, Oster ME. Association of US State Implementation of newborn screening policies for critical congenital heart disease with early infant cardiac deaths. JAMA. 2017; 318(21): 2111–2118. doi: https://doi.org/10.1001/jama.2017.17638
Organización Mundial de la Salud (OMS). Recomendaciones de la OMS sobre cuidados maternos y neonatales para una experiencia posnatal positiva. Hum Reprod Program. 2022; 1–12. doi: https://doi.org/10.1002/n/a
Iskander I, Gamaleldin R. Acute bilirubin encephalopathy: Some lessons learned. Semin Perinatol. 2021; 45(1): 151353. doi: https://doi.org/10.1016/j.semperi.2020.151353
Therrell BL, Padilla CD. Newborn screening in the developing countries. Curr Opin Pediatr. 2018; 30(6): 734–739. doi: https://doi.org/10.1097/MOP.0000000000000686
Castiñeras DE, Couce ML, Marin JL, González-Lamuño D, Rocha H. Newborn screening for metabolic disorders in Spain and worldwide. An Pediatr (Engl Ed). 2019; 91(2): 128.e1-128.e14. doi: https://doi.org/10.1016/j.anpedi.2019.03.012
Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics. 2006; 117(5). doi: https://doi.org/10.1542/peds.2005-2633R
Grosse SD. Does newborn screening save money? The difference between cost-effective and cost-saving interventions. J Pediatr. 2005; 146(2): 168–170. doi: https://doi.org/10.1016/j.jpeds.2004.10.004
Castilla-Rodríguez I, Vallejo-Torres L, Couce ML, Valcárcel-Nazco C, Mar J, Serrano-Aguilar P. Cost-effectiveness methods and newborn screening assessment. Adv Exp Med Biol. 2017; 1031: 267–281. doi: https://doi.org/10.1007/978-3-319-69535-4_14
Nazco CV, Pérez LG, Linertová R, Castilla I, Vallejo L, Serrano-Aguilar P. Cost-effectiveness methods of newborn screening assessment. Rev Esp Salud Publica. 2021; 95. doi: https://doi.org/10.4158/2021/01
Mallmann MB, Tomasi YT, Boing AF. Neonatal screening tests in Brazil: prevalence rates and regional and socioeconomic inequalities. J Pediatr (Rio J). 2020; 96(4): 487–494. doi: https://doi.org/10.1016/j.jped.2019.10.002
Tamizaje auditivo: consideraciones para su implementación. Washington, D.C.: Organización Panamericana de la Salud; 2021. doi: https://doi.org/10.37774/9789275324912
Macías-Tolosa C, Guzmán L, Gómez Ávila N, Paredes Aguirre D, Martínez H. Caracterización de los pacientes con tamizaje auditivo neonatal anormal en el Hospital Universitario Clínica San Rafael, durante los años 2018-2020. Acta Otorrinolaringol Cir Cabeza Cuello. 2022; 50(1): 51–57. doi: https://doi.org/10.29104/AOCCC.V50I1.453
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Jorge Alvarado-Socarras, Edgar Fabián Manrique-Hernández, Luisa Parra Rodas